CONFALONIERI, Marco

CONFALONIERI, Marco  

Dipartimento Universitario Clinico di Scienze mediche, chirurgiche e della salute  

Docenti di ruolo di IIa fascia  

Mostra records
Risultati 1 - 20 di 343 (tempo di esecuzione: 0.039 secondi).
Titolo Data di pubblicazione Autori File
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 1-gen-2023 Balduit, AndreaVidergar, RomanaZacchi, PaolaMangogna, AlessandroAgostinis, ChiaraBottin, CristinaSalton, FrancescoConfalonieri, PaolaRocca, AndreaZanconati, FabrizioConfalonieri, MarcoBulla, Roberta +
184 Complement score: A novel prognostic tool in malignant pleural mesothelioma? 1-gen-2023 Balduit, AndreaMangogna, AlessandroAgostinis, ChiaraBottin, CristinaSalton, FrancescoZanconati, FabrizioConfalonieri, MarcoBulla, Roberta +
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation 1-gen-2005 Confalonieri M. +
A Multicenter Study of Post-COVID-19 Interstitial Lung Syndrome 1-gen-2021 Marco Confalonieri +
A novel approach based on low field nuclear magnetic resonance for the detection of the pathological components of the sputum of cystic fibrosis patients 1-gen-2017 ABRAMI, MICHELAVENTURA, ALESSANDROCONFALONIERI, MarcoGRASSI, GABRIELEGRASSI, Mario +
A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients 1-gen-2018 Abrami, MichelaMaschio, MassimoVentura, AlessandroConfalonieri, MarcoDapas, BarbaraGrassi, GabrieleGrassi, Mario +
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 1-gen-2024 Salton, FrancescoTrotta, LilianaMondini, LucreziaAndrisano, Alessia GiovannaReccardini, NicolòConfalonieri, PaolaAntonaglia, CaterinaConfalonieri, MarcoRuaro, Barbara +
A preliminary open label controlled trial with bosentan in patients affected by chronic thromboembolic pulmonary hypertension (CTEPH). 1-gen-2006 Confalonieri M +
A real-life multicentric National study on nintedanib in severe idiopathic pulmonary fibrosis 1-gen-2018 Confalonieri Marco +
A retrospective study of endobronchial ultrasound transbronchial needle aspiration versus conventional transbronchial needle aspiration in diagnosis/staging of hilar/mediastinal lymph node in lung cancer: Which role in clinical practice? 1-gen-2019 Confalonieri, Marco +
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 1-gen-2024 Salton, FRispoli, MConfalonieri, PDe Nes, ASalotti, ARuaro, BHarari, SRocca, AD'Onofrio, AManzoni, LConfalonieri, M +
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 1-gen-2020 Albani S.Pinamonti B.Fabris E.Stolfo D.Perkan A.Gregorio C.Barbati G.Confalonieri M.Sinagra G. +
Acute respiratory distress syndrome 1-gen-2017 Confalonieri, MarcoSalton, Francesco +
Acute respiratory failure in patients with severe community-acquired pneumonia: A prospective randomized evaluation of noninvasive ventilation 1-gen-1999 Confalonieri M. +
Added BiPAP* vs. conventional therapy in acute respiratory failure due to exacerbation of COPD. 1-gen-1995 Confalonieri M +
Airways acidification in asthma studied by means of induced sputum: a study of feasibility and correlation with disease control and severity 1-gen-2006 Confalonieri M +
all in overnight peak expiratory flow is correlated to sputum eosinophilia in nocturnal asthma. 1-gen-1998 Confalonieri M +
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement 1-gen-2018 Confalonieri, Marco +
Alveolar Epithelial Type II Cells 1-gen-2022 Confalonieri MarcoSalton FrancescoRuaro BarbaraMaria Concetta VolpeConfalonieri Paola
An adalimumab-induced late-onset immune reconstitution inflammatory syndrome treated with adalimumab 1-gen-2018 Marco ConfalonieriNicola Di MeoGiovanni DamianiGiusto Trevisan +